Key takeaways
- The side effects of semaglutide are mostly gastrointestinal: nausea, diarrhea, vomiting, constipation and stomach pain, followed by headache, fatigue and dizziness.
- Semaglutide side effects start as the dose goes up, most often in the first weeks of treatment and after each step to a higher dose.
- Semaglutide can cause fatigue and headaches, and both were reported more often than on placebo.
- The serious side effects of semaglutide are pancreatitis, gallbladder disease, acute kidney injury from dehydration, severe gastrointestinal reactions and serious allergic reactions.
- Semaglutide carries a boxed warning for thyroid C-cell tumors because it caused them in rodents, and it is unknown whether it does in humans.
- Compounded semaglutide is not FDA-approved and is not the same as a brand-name product.
Short Answer
What Are the Side Effects of Semaglutide?
The side effects of semaglutide are mostly gastrointestinal: nausea, diarrhea, vomiting, constipation and stomach pain, followed by headache, fatigue and dizziness. In the trials behind the FDA-approved Wegovy labeling, 44% of people taking semaglutide 2.4 mg reported nausea compared with 16% on placebo.
Serious side effects are much less common. They include pancreatitis, gallbladder disease, dehydration that strains the kidneys and severe allergic reactions, all listed in the same labeling. The drug also carries a boxed warning about thyroid C-cell tumors seen in rodents.
If you are weighing treatment, Protocol Health's page on semaglutide explains how a provider screens for these risks first, and our short assessment starts the process.
So the realistic picture is common, usually manageable stomach side effects and a short list of rare serious ones that you and your prescriber should know before the first dose.
Common
What Are the Most Common Semaglutide Side Effects?
The most common semaglutide side effects are nausea, diarrhea, vomiting, constipation and abdominal pain, each far more frequent than on placebo. The table below shows selected rows from the label's adverse reaction table for adults on the 2.4 mg weekly dose in three trials of 2,116 people on semaglutide and 1,261 on placebo (FDA-approved Wegovy labeling).
| Side effect | Semaglutide 2.4 mg (%) | Placebo (%) |
|---|---|---|
| Nausea | 44 | 16 |
| Diarrhea | 30 | 16 |
| Vomiting | 24 | 6 |
| Constipation | 24 | 11 |
| Abdominal pain | 20 | 10 |
| Headache | 14 | 10 |
| Fatigue | 11 | 5 |
| Indigestion (dyspepsia) | 9 | 3 |
| Dizziness | 8 | 4 |
| Hair loss | 3 | 1 |
These are reports during the trials, so some of the placebo rate is background illness. The gap between the two columns is the better guide to what the drug adds. Hair loss is covered in detail in our guide to semaglutide hair loss.
So most people on semaglutide can expect at least one stomach-related side effect at some point, and nausea is the one to plan for.
Stomach
Does Semaglutide Cause Nausea and Diarrhea?
Yes, semaglutide commonly causes nausea and diarrhea, and they are the two gastrointestinal side effects people notice most. The label reports nausea in 44% and diarrhea in 30% of adults taking 2.4 mg, and constipation in 24% (FDA-approved Wegovy labeling).
In the STEP 1 trial of 1,961 adults, nausea and diarrhea were typically transient and mild-to-moderate in severity and subsided with time. More people on semaglutide than placebo stopped treatment because of gastrointestinal events (59 people, 4.5%, versus 5 people, 0.8%).
Across the three label trials, 1.8% of people on semaglutide stopped because of nausea, 1.2% because of vomiting and 0.7% because of diarrhea (FDA-approved Wegovy labeling). Severe gastrointestinal reactions were reported in 4.1% of people on the injection and 0.9% on placebo.
So the gastrointestinal side effects of semaglutide are common and usually mild, but a minority are severe enough to stop treatment.
Timing
When Do Semaglutide Side Effects Start?
Semaglutide side effects start as the dose goes up, most often in the first weeks of treatment and after each step to a higher dose. The label says the dose escalation schedule exists to reduce the risk of gastrointestinal adverse reactions.
That schedule is the semaglutide side effects timeline in practice. The injection starts at 0.25 mg once weekly for weeks 1 through 4, then 0.5 mg for weeks 5 through 8, 1 mg for weeks 9 through 12 and 1.7 mg for weeks 13 through 16, before the maintenance dose (FDA-approved Wegovy labeling). This is what the labeled schedule gives, not a dose for you.
The first week is the lowest dose, and trial data do not give a single onset day. Symptoms may return briefly after each step up.
If a dose is not tolerated, the label allows delaying the next step for 4 weeks.
So side effects begin early and tend to return briefly with each increase, which is why the pace of the steps matters.
Duration
How Long Do Semaglutide Side Effects Last?
Most semaglutide side effects fade within days to weeks of starting or changing a dose, and the STEP 1 trial described the main ones as transient and subsiding with time. The trials did not report one fixed number of days for everyone.
That matters because semaglutide stays in the body for a long time. The label notes a long half-life of semaglutide and advises stopping at least 2 months before a planned pregnancy, so effects can linger after the last dose.
Side effects that do not settle, get worse or come with dehydration should be reported to your prescriber rather than waited out.
So most people see the stomach side effects ease as their body adjusts, and persistent ones are a reason to adjust the plan, not to push through.
Fatigue
Does Semaglutide Cause Fatigue and Headaches?
Semaglutide can cause fatigue and headaches, and both were reported more often than on placebo. In the label trials fatigue was reported by 11% of people on semaglutide versus 5% on placebo, headache by 14% versus 10% and dizziness by 8% versus 4% (FDA-approved Wegovy labeling).
Part of this may be indirect. Vomiting, diarrhea and eating much less can cause dehydration, and the label warns that dehydration can lead to acute kidney injury. Tell your prescriber if tiredness comes with dizziness, very dark urine or little urination.
So semaglutide side effects like fatigue and headache are fairly common, usually mild, and worth mentioning if they come with signs of dehydration.
Serious
What Are the Serious Side Effects of Semaglutide?
The serious side effects of semaglutide are pancreatitis, gallbladder disease, acute kidney injury from dehydration, severe gastrointestinal reactions and serious allergic reactions. Each is listed in the warnings of the FDA-approved Wegovy labeling.
- Pancreatitis: reported with GLP-1 drugs including Wegovy, with persistent or severe abdominal pain sometimes radiating to the back (dailymed.nlm.nih.gov).
- Gallbladder disease: cholelithiasis (gallstones) in 1.6% on semaglutide versus 0.7% on placebo, and cholecystitis in 0.6% versus 0.2% (dailymed.nlm.nih.gov).
- Severe gastrointestinal reactions: 4.1% on the injection versus 0.9% on placebo; not recommended in people with severe gastroparesis (dailymed.nlm.nih.gov).
- Acute kidney injury: postmarketing reports, mostly after vomiting, diarrhea or nausea led to dehydration (dailymed.nlm.nih.gov).
- Serious allergic reactions: anaphylaxis and angioedema have been reported (dailymed.nlm.nih.gov).
- Faster heart rate: mean resting increases of 1 to 4 beats per minute versus placebo (dailymed.nlm.nih.gov).
- Low blood sugar when combined with insulin or sulfonylurea drugs, and diabetic retinopathy complications in people with type 2 diabetes (dailymed.nlm.nih.gov).
These are the reasons semaglutide needs a prescriber. MedlinePlus tells patients to report any history of pancreatitis, diabetic retinopathy, severe stomach problems, gallbladder disease or kidney disease before starting.
So the serious side effects are uncommon but real, and several of them begin with symptoms that look like ordinary stomach upset.
Thyroid
Does Semaglutide Cause Cancer?
Semaglutide carries a boxed warning for thyroid C-cell tumors because it caused them in rodents, and it is unknown whether it does in humans. The boxed warning says human relevance has not been determined, so this is a precaution, not a proven human cancer risk.
For that reason the drug is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (dailymed.nlm.nih.gov). Tell your prescriber about any such history, or a neck lump, trouble swallowing or a hoarse voice that does not go away.
So cancer risk is a question of screening: the warning is real, the human risk is unproven, and your family history decides whether it is an option at all.
Long Term
What Are the Long-Term Side Effects of Semaglutide?
The long-term side effects of semaglutide are best seen in a cardiovascular outcomes trial in which 8,803 people took semaglutide for a median of 37.3 months. In that trial 16% of people on semaglutide stopped the drug because of an adverse event versus 8% on placebo (FDA-approved Wegovy labeling).
The weight-loss trials ran up to 68 weeks, and in the 68-week STEP 1 trial discontinuation for gastrointestinal events was 4.5% versus 0.8%. Beyond that, the long-term picture is still being built from real-world use.
Keep scheduled check-ins during treatment, because gallbladder, kidney and heart-rate effects are monitored over time rather than felt on day one.
So long-term use has been studied for a few years, the main long-term safety signal was more people stopping because of adverse events, and ongoing monitoring is part of safe treatment.
Women and Men
Are Semaglutide Side Effects Different in Women and Men?
Semaglutide side effects are not very different in women and men: the label's main table pools everyone, and the one sex split it reports is hair loss, 4% of women versus 0.9% of men on 2.4 mg (2% and 0 on placebo). The participants in the three weight-loss trials were 71% female, so the rates in the table above mostly reflect women.
Pregnancy is the clear sex-specific issue. The label says to discontinue semaglutide when pregnancy is recognized and at least 2 months before a planned pregnancy (dailymed.nlm.nih.gov). Anyone who could become pregnant should discuss this with a prescriber before starting.
So semaglutide side effects in women and men look largely the same, apart from hair loss, and the real difference is pregnancy planning.
Compounded
Are Compounded Semaglutide Side Effects Different?
Compounded semaglutide is not FDA-approved, and its side effects have not been tested in the trials behind the Wegovy numbers above. The FDA says it has received reports of adverse events, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide.
Those errors came from patients and sometimes clinicians measuring or calculating the wrong dose. The FDA also states it is not aware of a lawful basis for compounding with the salt forms, semaglutide sodium and semaglutide acetate (fda.gov).
Protocol Health prescribes compounded semaglutide, which is a commercial interest worth naming. That is why the pharmacy source and the dosing instructions should be part of any consultation, and why you should ask about both.
So no trial has measured compounded semaglutide's side effects, and the added risk is in dosing and product quality, and the FDA's guidance is to use a state-licensed pharmacy and ask your prescriber how to measure each dose.
Managing
How Can You Manage Semaglutide Side Effects?
The main way to manage semaglutide side effects is to slow the dose increases, and the label supports this by letting a prescriber delay escalation for 4 weeks if a dose is not tolerated. Never change or skip doses yourself.
Day to day, what you eat can help. Our guide to what to eat on semaglutide covers protein, portion size and foods to limit.
Staying hydrated matters most when you have nausea, vomiting or diarrhea, because the label links dehydration to kidney injury (dailymed.nlm.nih.gov). If you are on insulin or a sulfonylurea, your prescriber may need to lower that dose.
So management starts with the pace of the dose schedule, then food and fluids, and it ends with a prescriber who is told early when something is wrong.
Call a Doctor
When Should You Call a Doctor About Semaglutide Side Effects?
Call a doctor about semaglutide side effects right away for severe or persistent abdominal pain, especially pain that spreads to your back, because it can signal pancreatitis (FDA label). Stop the injection and get care if you have swelling of the face or throat or trouble breathing.
Call as well for vomiting or diarrhea that stops you keeping fluids down, signs of dehydration such as dark urine, pain in the upper right abdomen or yellowing of the skin, a lump in the neck, or vision changes if you have diabetes.
Tell every clinician and anesthesia team that you take semaglutide before a procedure, because the label reports pulmonary aspiration under anesthesia with GLP-1 drugs.
So call early for severe pain, dehydration, allergic symptoms or a neck lump, and mention semaglutide before any surgery.
Our Approach
Semaglutide Treatment at Protocol Health
At Protocol Health, semaglutide treatment starts with a medical history that screens for thyroid cancer history, pancreatitis, gallbladder disease and pregnancy plans, followed by a review of the dose schedule and side effects with your provider. We prescribe GLP-1 weight-loss medication, including compounded semaglutide, which is a commercial interest worth naming. Compounded semaglutide is not FDA-approved and is not the same product as Wegovy or Ozempic.
Visits take place at our Scarsdale clinic or by telehealth in New York, New Jersey, Connecticut, Florida and California. Your provider may recommend treatment, a different medication or none, and no result is guaranteed.
Read about semaglutide at Protocol Health, our medical weight loss program, or take the Protocol Health quiz to start a consultation. If semaglutide does not suit you, compare it with tirzepatide in our guide to tirzepatide versus semaglutide. This guide is educational and is not medical advice; read our safety information, and decisions about medication belong with a licensed provider who knows your history.
FAQ
Frequently Asked Questions
What are the most common side effects of semaglutide?
Nausea, diarrhea, vomiting, constipation and abdominal pain are the most common. In the Wegovy trials nausea affected 44% of people on semaglutide versus 16% on placebo (FDA label). Most are mild to moderate and tied to dose increases.
How long do semaglutide side effects last?
Most fade within days to weeks of a dose change, and the main trial called nausea and diarrhea transient and subsiding with time. No trial gave one fixed duration, so ask your prescriber if symptoms persist.
When do semaglutide side effects start?
They usually start in the first weeks and after each dose increase. The label's step-up schedule, 0.25 mg for 4 weeks and then higher steps every 4 weeks, is designed to reduce stomach side effects.
Does semaglutide cause thyroid cancer?
It caused thyroid C-cell tumors in rodents, so the label carries a boxed warning, but it is unknown whether it does in humans. People with a personal or family history of medullary thyroid carcinoma or MEN 2 should not take it.
Are compounded semaglutide side effects worse?
Not necessarily worse, but compounded semaglutide is not FDA-approved. The FDA has received reports of adverse events linked to dosing errors with compounded injectable semaglutide, so measuring the dose correctly matters.
Can you stop semaglutide cold turkey?
Talk to your prescriber before stopping, because they can adjust the plan for you. The label notes semaglutide has a long half-life, so effects can persist after the last dose, and it asks for at least 2 months off before a planned pregnancy.
Explore
Related at Protocol Health
Talk to a provider about semaglutideMedical disclaimer
This article is for education only and is not medical advice, diagnosis, or treatment. Talk to a licensed clinician before starting, stopping, or changing any medication.
Important safety information
Compounded medications are not FDA-approved and are not the same as brand-name products.
References
- FDA-approved Wegovy labeling. National Institutes of Health. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- typically transient and mild-to-moderate in severity and subsided with time. PubMed. https://pubmed.ncbi.nlm.nih.gov/33567185/
- MedlinePlus. medlineplus.gov. https://medlineplus.gov/druginfo/meds/a618008.html
- reports of adverse events, some requiring hospitalization. U.S. Food and Drug Administration. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
Why trust our physicians
Every article is reviewed by a licensed physician on our medical team and is kept current by our editorial team. Read our editorial policy and our medical review process.
- Medically reviewed by
- Richard Dentico, MD on
- Written by
- Protocol Health Editorial Team
- First published
- Last updated
See an error? Email care@protocolhealthmd.com and we will review it.
More on Semaglutide
- Semaglutide Hair Loss: Why It Happens and What It Means
- Switching From Semaglutide to Tirzepatide: How It Works and What to Expect
- Semaglutide in Florida: The Rules Behind the Prescription
- Semaglutide in NYC: How Prescribing and Care Actually Work
